← Open Payments lookup

LEROY BELL: Open Payments

NPI 1568434181 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$9,175 in 129 payments from 12 companies in 2025. Trend: 2023 $2,560 · 2024 $2,480 · 2025 $9,175

Speaker / faculty: $6,650Food & beverage: $2,403Education: $121
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$7,017
Neurocrine BioSciences, Inc.23$489
E.R. Squibb & Sons, L.L.C.18$410
Janssen Pharmaceuticals, Inc10$257
Otsuka America Pharmaceutical, Inc.10$220
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$216
ABBVIE INC.25$206
Alkermes, Inc.9$181
Vanda Pharmaceuticals Inc.3$75
Luye Pharma (USA) Ltd.2$46

Products named: UZEDY, INGREZZA, COBENFY, CAPLYTA, VRAYLAR, INVEGA SUSTENNA, ARISTADA, ABILIFY MAINTENA.

Industry payments across MD — which companies pay providers there.